CD40LG and hyperinsulinemic hypoglycemia, familial, 4: For example, in patients who had undergone alloHSCT for CD40 ligand deficiency, in survivors who were able to cease immunoglobulin replacement therapy, T lymphocyte chimerism was over 50% donor (Ferrua et al., 2019b).